NeuroSense Therapeutics Ownership | Who Owns NeuroSense Therapeutics?

NeuroSense Therapeutics Ownership Summary

NeuroSense Therapeutics is owned by 1.11% institutional investors, 25.55% insiders, and 73.35% retail investors. Yorkville advisors global, lp is the largest institutional shareholder, holding 0.39% of NRSN shares. Fidelity Nasdaq Composite Index is the top mutual fund, with 0.05% of its assets in NeuroSense Therapeutics shares.

NRSN Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	NeuroSense Therapeutics	1.11%	25.55%	73.35%
Sector	Healthcare Stocks	232.01%	10.74%	-142.75%
Industry	Biotech Stocks	381.47%	10.55%	-292.02%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Yorkville advisors global, lp	100.00K	0.39%	$76.90K
Squarepoint ops	95.38K	0.38%	$119.22K
Meitav investment house	40.00K	0.16%	$30.76K
Ubs group	30.87K	0.12%	$23.74K
Commonwealth equity services	22.77K	0.09%	$17.52K
Two sigma investments, lp	21.09K	0.08%	$26.36K
Pathstone	16.53K	0.07%	$12.71K
Geode capital management	15.87K	0.06%	$12.20K
Sbi securities	1.46K	0.01%	$1.12K
Jones financial companies lllp	1.00K	0.00%	$1.24K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Yorkville advisors global, lp	100.00K	0.05%	$76.90K
Meitav investment house	40.00K	0.00%	$30.76K
Squarepoint ops	95.38K	0.00%	$119.22K
Jessup wealth management	500.00	0.00%	$385.00
Commonwealth equity services	22.77K	-	$17.52K
Cwm	-	-	-
Marshall wace, llp	-	-	-
Jane street group	-	-	-
Cantor fitzgerald, l. p.	-	-	-
Two sigma securities	-	-	-

Top Buyers

Holder	Shares	% Assets	Change
Yorkville advisors global, lp	100.00K	0.05%	100.00K
Squarepoint ops	95.38K	0.00%	45.45K
Two sigma investments, lp	21.09K	-	21.09K
Pathstone	16.53K	-	16.53K
Ubs group	30.87K	-	16.21K

Top Sellers

Holder	Shares	% Assets	Change
Armistice capital	-	-	-1.58M
Cantor fitzgerald, l. p.	-	-	-79.49K
Renaissance	-	-	-71.10K
Morgan stanley	-	-	-66.40K
Xtx topco	-	-	-33.71K

New Positions

Holder	Shares	% Assets	Change	Value
Two sigma investments, lp	21.09K	-	21.09K	$26.36K
Pathstone	16.53K	-	16.53K	$12.71K
Jessup wealth management	500.00	0.00%	500.00	$385.00

Sold Out

Holder	Change
Qube research	-54.00
Total investment management	-500.00
Cwm	-1.00K
Hurley capital	-6.53K
Bnp paribas arbitrage, snc	-6.80K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2025	10	-	281,678	1.35%	1	92.63%	6	100.00%	1	-66.67%
Sep 30, 2025	10	-37.50%	277,925	-38.24%	1	25.32%	3	-72.73%	3	50.00%
Jun 30, 2025	15	36.36%	449,544	130.66%	2	294.96%	10	233.33%	2	-33.33%
Mar 31, 2025	11	-15.38%	194,892	-69.85%	-	6.54%	3	-70.00%	3	200.00%
Dec 31, 2024	13	85.71%	646,513	186.89%	3	229.84%	10	150.00%	1	-

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Fidelity Nasdaq Composite Index	15.87K	0.05%	-

NRSN Ownership FAQ

Who Owns NeuroSense Therapeutics?

NeuroSense Therapeutics shareholders are primarily institutional investors at 1.11%, followed by 25.55% insiders and 73.34% retail investors. The average institutional ownership in NeuroSense Therapeutics's industry, Biotech Stocks , is 381.47%, which NeuroSense Therapeutics falls below.

Who owns the most shares of NeuroSense Therapeutics?

NeuroSense Therapeutics’s largest shareholders are Yorkville advisors global, lp (100K shares, 0.39%), Squarepoint ops (95.38K shares, 0.38%), and Meitav investment house (40K shares, 0.16%). Together, they hold 0.93% of NeuroSense Therapeutics’s total shares outstanding.

Does Blackrock own NeuroSense Therapeutics?

BlackRock is not among the top 10 institutional shareholders of NeuroSense Therapeutics.

Who is NeuroSense Therapeutics’s biggest shareholder by percentage of total assets invested?

Yorkville advisors global, lp is NeuroSense Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.05% of its assets in 100K NeuroSense Therapeutics shares, valued at 76.9K$.

Who is the top mutual fund holder of NeuroSense Therapeutics shares?

Fidelity Nasdaq Composite Index is the top mutual fund holder of NeuroSense Therapeutics shares, with 0.05% of its total shares outstanding invested in 15.87K NeuroSense Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools